Locally Advanced Cancer of the Head of the Pancreas Successfully Treated by Pancreaticoduodenectomy without Superior Mesenteric Vein Reconstruction-Reference-Cited by-同舟云学术

Locally Advanced Cancer of the Head of the Pancreas Successfully Treated by Pancreaticoduodenectomy without Superior Mesenteric Vein Reconstruction

Published:2021 Issue:4 Volume:82 Page:789-793
ISSN:1345-2843
Container-title:Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
language:en
Short-container-title:Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc)

Author:

ASHIZAWA Yosuke¹,NOJIMA Hiroyuki¹,SHIMIZU Hiroaki¹,YOSHITOMI Hideyuki¹,FURUKAWA Katsunori¹,OHTSUKA Masayuki¹

Affiliation:

1. Department of General Surgery, Graduate School of Medicine, Chiba University

Publisher

Japan Surgical Association

Subject

General Engineering

Link

https://www.jstage.jst.go.jp/article/jjsa/82/4/82_789/_pdf

Reference19 articles.

1. 1) Egawa S, Toma H, Ohigashi H, et al : Japan Pancreatic Cancer Registry ; 30th year anniversary : Japan Pancreas Society. Pancreas 2012 ; 41 : 985-992

2. 2) Okusaka T, Ikari T, Isayama H, et al : Efficacy and safety of Gemcitabine plus S-1 treatment in locally advanced and metastatic pancreatic cancer. A pooled analysis of three randomized trials using updated individual patient data. Eur J Cancer 2013 ; 49 : S6-18

3. 3) 元井冬彦，岡田　良，川口　桂他:Borderline Resectable（BR）膵癌に対する治療戦略:NCCN定義の再考と術前GS療法の意義．癌の臨　2014;60:273-277

4. 4) Gharaibeh M, McBride A, Bootman JL, et al : Economic evaluation for the UK of nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreas cancer. Br J Cancer 2015 ; 112 : 1301-1305

5. 5) Conroy T, Desseigne F, Ychou M, et al : FOLFILINOX versus gemcitabine for metastatic pancreaic cancer. N Engl J Med 2011 ; 364 : 1817-1825